ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

34.30 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	647
Open	34.30
Bid (Size)	34.27 (200)
Ask (Size)	34.80 (5,300)
Prev. Close	34.30
Today's Range	34.30 - 34.30
52wk Range	25.28 - 46.48
Shares Outstanding	154,420,772
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum ↗

April 04, 2026

Via Chartmill

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs.

Via The Motley Fool

Performance

YTD	+17.1%	+17.1%
1 Month	+8.9%	+8.9%
3 Month	+11.7%	+11.7%
6 Month	-1.6%	-1.6%
1 Year	-10.2%	-10.2%

More News

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗

March 16, 2026

Via The Motley Fool

TG Therapeutics Inc (NASDAQ:TGTX) Presents a Compelling Momentum Case with Strong Growth and Technical Setup ↗

March 14, 2026

Via Chartmill

TG Therapeutics (TGTX) Q4 2025 Earnings Transcript ↗

February 26, 2026

Via The Motley Fool

TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook ↗

February 26, 2026

Via Chartmill

Soleus Adds a Significant Number of Celcuity Shares ↗

February 13, 2026

Via The Motley Fool

TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' ↗

February 09, 2026

Via Stocktwits

Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares ↗

February 02, 2026

Via The Motley Fool

TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗

January 15, 2026

Via Stocktwits

TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗

November 03, 2025

Via Stocktwits

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Earnings Preview For TG Therapeutics ↗

October 31, 2025

Via Benzinga

Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗

January 14, 2026

Via Stocktwits

TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗

January 13, 2026

Via Stocktwits

These stocks are moving in today's after hours session ↗

January 13, 2026

Via Chartmill

TG Therapeutics TGTX Q3 2025 Earnings Transcript ↗

November 27, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗

November 10, 2025

Via Investor's Business Daily

Hussman Sells Off All 21,000 CHKP Shares Valued At $4.65 Million ↗

November 03, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Via Benzinga

Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat ↗

November 03, 2025

Via Investor's Business Daily

Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗

October 16, 2025

Via Benzinga

TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup ↗

October 07, 2025

Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?

Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does TG Therapeutics, Inc. - Common Stock trade on?

TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?

The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market

What is the current price of TG Therapeutics, Inc. - Common Stock?

The current price of TG Therapeutics, Inc. - Common Stock is 34.30

When was TG Therapeutics, Inc. - Common Stock last traded?

The last trade of TG Therapeutics, Inc. - Common Stock was at 04/16/26 04:00 PM ET

What is the market capitalization of TG Therapeutics, Inc. - Common Stock?

The market capitalization of TG Therapeutics, Inc. - Common Stock is 5.30B

How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?

TG Therapeutics, Inc. - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.